Search results for "galant"

showing 10 items of 25 documents

Fontenelle ou la tendresse philosophe . Introduction

2015

International audience; Philosophe, écrivain, mathématicien, Académicien, Fontenelle (1657-1757) produit une œuvre dont ce volume montre l’unité dans une écriture philosophique définie comme réflexion sur le mouvement ordinaire de la pensée et sur l’historicité des idées, à partir de toutes les œuvres de l’esprit et de la culture. Cette édition scientifique de plus de vingt œuvres et d’extraits de l’Histoire de l’Académie royale des sciences, précédée d’un essai introductif, montre une pratique réflexive des discours qui vise l’émancipation de l’esprit par la réappropriation de ses propres œuvres. Fontenelle y ajoute un esprit singulier qui consiste à éveiller des idées chez son interlocute…

Lumières[SHS.PHIL] Humanities and Social Sciences/PhilosophyélogesFontenelle[SHS.PHIL]Humanities and Social Sciences/PhilosophyAcadémie royale des sciencesPhilosophiematérialismegalanterie
researchProduct

Controlled Iontophoretic Delivery in Vitro and in Vivo of ARN14140—A Multitarget Compound for Alzheimer’s Disease

2019

ARN14140 is a galantamine-memantine conjugate that acts upon both cholinergic and glutamatergic pathways for better management of Alzheimer's disease. Poor oral bioavailability and pharmacokinetics meant that earlier preclinical in vivo studies employed intracerebroventricular injection to administer ARN14140 directly to the brain. The aim of the present study was to evaluate the feasibility of using constant current transdermal iontophoresis for the noninvasive systemic delivery of ARN14140 and to quantify the amounts present in the blood and the brain. Preliminary experiments in vitro were performed using porcine skin and validated with human skin. Cumulative ARN14140 permeation across th…

MaleSwineSkin Absorptionbrain deliveryBiological AvailabilityPharmaceutical ScienceHuman skin02 engineering and technologyPharmacologyAdministration Cutaneous030226 pharmacology & pharmacyPermeability03 medical and health sciences0302 clinical medicineDrug StabilityPharmacokineticsIn vivoDrug DiscoveryARN14140AnimalsBrain/metabolismHumansSkin/metabolismMedicineTissue DistributionRats WistarNootropic Agents/administration & dosage/pharmacokineticsTransdermalddc:615galantamine-memantine conjugateAlzheimer Disease/drug therapyIontophoresisbusiness.industryGalantamine/administration & dosage/pharmacokineticsiontophoresiIontophoresisMemantine/administration & dosage/pharmacokinetics021001 nanoscience & nanotechnologyIn vitroRatsBioavailabilityHeterocyclic Compounds 4 or More Rings/administration & dosage/pharmacologytransdermalFeasibility StudiesMolecular MedicineCholinergic0210 nano-technologybusinessMolecular Pharmaceutics
researchProduct

Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for mul…

2016

Abstract Background Acetylcholinesterase inhibitors (AceI) and memantine might prove useful in bipolar disorder (BD) given their neuroprotective and pro-cognitive effects, as highlighted by several case reports. We aimed to systematically review the efficacy and safety of AceI and memantine across multiple outcome dimensions in BD. Methods Systematic PubMed and SCOPUS search until 04/17/2015 without language restrictions. Included were randomized controlled trials (RCTs), open label studies and case series of AceI or memantine in BD patients reporting quantitative data on depression, mania, psychotic symptoms, global functioning, or cognitive performance. We summarized results using a best-…

Malelaw.inventionpsychosis.0302 clinical medicinePiperidinesRandomized controlled triallawDonepezilDonepezilRandomized Controlled Trials as Topicbipolar disorderClinical Trials as TopicEvidence-Based MedicineDepressionMemantineMiddle AgedManiaPsychiatry and Mental healthClinical PsychologyTreatment Outcomeacetylcholinesterase inhibitorsdepressionIndansFemalemedicine.symptomPsychologyManiamedicine.drugAdultmedicine.medical_specialtyBipolar disorderPlaceboBipolar disorder Acetylcholinesterase inhibitors Memantine Depression Mania Psychosis03 medical and health sciencesmaniaMemantineInternal medicinemedicineGalantamineHumansBipolar disorderAcetylcholinesterase inhibitors; Bipolar disorder; Depression; Mania; Memantine; Psychosis.PsychiatryDepressive DisorderGalantaminePsychosismedicine.disease030227 psychiatryAcetylcholinesterase inhibitorsMoodPsychotic DisordersAcetylcholinesterase inhibitors; Bipolar disorder; Depression; Mania; Memantine; Psychosis; Psychiatry and Mental Health; Clinical PsychologyCase-Control StudiesmemantineCholinesterase InhibitorsExcitatory Amino Acid Antagonists030217 neurology & neurosurgeryJournal of Affective Disorders
researchProduct

Le “plaisir sucré” de la duchesse : un point sur la production du « galant de Madame » à la fin du Moyen Âge. https://preo.u-bourgogne.fr/crescentis/…

2021

Among the range of products elaborated in the Dukes of Burgundy vineyards at the end of the Middle Ages, the galant is first quoted in 1383. This paper strives to shed new light upon the sources in which the galant appears, i.e. the accountability documentation of the Dukes’ vineyards. Our research focuses on two demesnes located near Dijon: Talant and Chenôve.The study of this rare product (2-4% of total production), which was certainly flavored with gentian, shows that the notion of fortified wine should be reconsidered for the 14th and 15th centuries. The galant was obtained only by heating white grape must in a cauldron, searching to reach a diminution of one- or two-thirds of the basic…

Moyen Âgefortified winemedicine[SHS.GEO] Humanities and Social Sciences/Geographyfemme[SDV.SA.AEP] Life Sciences [q-bio]/Agricultural sciences/Agriculture economy and politics[SDV.SA.AEP]Life Sciences [q-bio]/Agricultural sciences/Agriculture economy and politics[SHS.GEO]Humanities and Social Sciences/Geography[SHS.GENRE] Humanities and Social Sciences/Gender studiessherry[SDV.AEN] Life Sciences [q-bio]/Food and Nutritionfemale[SHS.HIST] Humanities and Social Sciences/HistoryBourgogneMiddle Agesvin cuit[SHS.HIST]Humanities and Social Sciences/History[SHS.GENRE]Humanities and Social Sciences/Gender studiesmédecine[SDV.AEN]Life Sciences [q-bio]/Food and NutritionBurgundygalant
researchProduct

Evaluation of Galantamine transbuccal absorption by reconstituted human oral epithelium and porcine tissue as buccal mucosa models: Part I

2008

Over the last decade, interest in delivering drugs through buccal mucosa has increased. As a major limitation in buccal drug delivery could be the low permeability of the epithelium, the aim of this study was to evaluate the aptitude of galantamine, useful in Alzheimer's disease, to penetrate the buccal mucosa. The evaluation of the ability of galantamine to permeate through the buccal epithelium was investigated using two permeation models. Firstly, in vitro permeation experiments were carried out using reconstituted human oral non-keratinised epithelium and Transwell diffusion cells system. Results were validated by ex vivo experiments using porcine buccal mucosa as membrane and Franz typ…

Pathologymedicine.medical_specialtySwinePharmaceutical ScienceAbsorption (skin)BiologyPermeabilityDiffusionstomatognathic systemPharmacokineticsSettore MED/28 - Malattie OdontostomatologichemedicineAnimalsHumansTransbuccal permeationCells CulturedGalantamineMouth MucosaAdministration BuccalEpithelial CellsGeneral MedicineBuccal administrationPermeationIn vitroEpitheliumstomatognathic diseasesKineticsmedicine.anatomical_structureSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryReconstituted human oral epithelium (HOE)Diffusion Chambers CultureCholinesterase InhibitorsPorcine buccal mucosaAlzheimer’s diseaseEx vivoBiotechnology
researchProduct

Von der symptomatischen zur kausalen Therapie?

2009

Until today the pharmacological therapy of Alzheimer’s disease (AD) is still limited to symptomatic temporary improvement or stabilization of cognitive performance and activities of daily living, and the reduction of neuropsychiatric symptoms of the disease. Available symptomatic treatment options are the acetylcholinesterase inhibitors (ACh-I) donepezil, galantamine, rivastigmine, and the partial N-Methyl-D-Aspartat-(NMDA)-antagonist memantine. Further substances with symptomatic targets, especially selective acetylcholine and histamine receptors, are currently under development. Numerous of disease-modifying substances mainly targeting components of the amyloidogenic pathway of AD are pre…

Rivastigminebusiness.industryMemantineDiseaseBioinformaticsAcetylcholinesteraseClinical trialPsychiatry and Mental healthchemistry.chemical_compoundPharmacotherapyNeurologychemistryGalantamineMedicineNeurology (clinical)businessDonepezilNeurosciencemedicine.drugFortschritte der Neurologie · Psychiatrie
researchProduct

Galantamine is an allosterically potentiating ligand of the human α4/β2 nAChR

2000

Galantamine (ReminyI ) is a novel drug treatment for mild to moderate Alzheimer's disease (AD). Originally established as a reversible inhibitor of the acetylcholine-degrading enzyme acetylcholinesterase (AChE), galantamine also acts as an allosterically potentiating ligand (APL) on nicotinic acetylcholine receptors (nAChR). Having previously established this second mode of action on nAChRs from murine brain, we demonstrate here the same action of galantamine on the most abundant nAChR in the human brain, the α4/β2 subtype. This nAChR-sensitizing action is not a common property of all, or most, AChE inhibitors, as is shown by the absence of this effect for other therapeutically applied AChE…

Rivastigminemedicine.medical_specialtyChemistryGeneral MedicinePharmacologyAcetylcholinesterasechemistry.chemical_compoundEndocrinologyNicotinic agonistNeurologyMechanism of actionTacrineInternal medicinemental disordersmedicineGalantamineNeurology (clinical)Metrifonatemedicine.symptomMode of actionmedicine.drugActa Neurologica Scandinavica
researchProduct

Melampsora allii-fragilis f. sp. galanthi-fragilis reported for first time to cause rust on Galanthus plicatus in Latvia

2010

In Europe, Melampsora allii-fragilis f. sp. galanthi-fragilis (syn. Melampsora galanthi-fragilis) has been reported on leaves of snowdrop (Galanthus nivalis) in Romania (Savulescu, 1953; Bagyanarayana, 2005) and on Galanthus plicatus in Ukraine (Gutsevich, 1952). The GBIF Database has additional records of this fungus on G. nivalis from Austria, Czech Republic and France but the USDA SMML Specimens Database has also records from Hungary and Poland. According to this database, the established distribution area of M. allii-fragilis f. sp. galanthi-fragilis is ‘Central Europe’. Melampsora allii-fragilis f. sp. galanthi-fragilis belongs to the heteroecious rust fungi that require two hosts to c…

Salix fragilisbiologyPlant ScienceFungusMelampsoraHorticulturebiology.organism_classificationSporeHerbariumHeteroeciousBotanyGeneticsTaxonomy (biology)Agronomy and Crop ScienceGalanthus nivalisPlant Pathology
researchProduct

Unconventional ligands and modulators of nicotinic receptors

2002

Evidence gathered from epidemiologic and behavioral studies have indicated that neuronal nicotinic receptors (nAChRs) are intimately involved in the pathogenesis of a number of neurologic disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. In the mammalian brain, neuronal nAChRs, in addition to mediating fast synaptic transmission, modulate fast synaptic transmission mediated by the major excitatory and inhibitory neurotransmitters glutamate and GABA, respectively. Of major interest, however, is the fact that the activity of the different subtypes of neuronal nAChR is also subject to modulation by substances of endogenous origin such as choline, the tryptophan …

SerotoninNeuroactive steroidPsychotomimetic drugReceptors NicotinicNeurotransmissionPharmacologyBiologyKynurenic AcidLigandsInhibitory postsynaptic potentialCholineCellular and Molecular Neurosciencechemistry.chemical_compoundKynurenic acidmental disordersmedicineAnimalsHumansPhencyclidineAnestheticsAmyloid beta-PeptidesGalantamineGeneral NeuroscienceGlutamate receptorNicotinic agonistnervous systemchemistryHallucinogensSteroidsNeurosciencemedicine.drugJournal of Neurobiology
researchProduct

Genetic diversity in five populations of Galanthus from Sicily using isozymes

2009

Settore BIO/01 - Botanica GeneraleSettore BIO/02 - Botanica SistematicaGalanthus flowering period polymorphism genetic variability
researchProduct